Estimaciones de analistas de Wall Street para Soligenix, Inc. (SNGX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 5 |
| Mantener | 3 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 8 |
| Calificación media (1-5) | 0.62 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-06 | $-0.12 | ||
| 2026-08-07 | $-0.12 | $-0.15 | +22.6% |
| 2026-05-08 | $-0.28 | $-0.30 | +6.7% |
| 2026-04-03 | $0.32 | $-0.27 | +218.5% |
| 2025-11-07 | $-0.58 | $-0.63 | +7.9% |
| 2025-08-14 | $-0.82 | $-0.79 | -3.8% |
| 2025-05-09 | $-1.06 | $-0.67 | -58.2% |
| 2025-03-21 | $-1.14 | $-0.95 | -20.0% |
Ratios de valoración
| Precio / Valor contable | 0.86 |
| EV / EBITDA | 0.36 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $10.4M | $5.4M | $5.2M | $3.2M | $1.9M | $33351 | $250000 | 0 | 0 | 0 |
| Coste de Ventas | $8.4M | $4.3M | $4.6M | $3.6M | $1.8M | $728640 | $550822 | $742048 | $119371 | 0 |
| Beneficio Bruto | $2.0M | $1.1M | $643733 | -$351776 | $109584 | -$695289 | -$300822 | -$742048 | -$119371 | 0 |
| I+D | $4.3M | $5.5M | $6.8M | $8.1M | $14.8M | $8.2M | $7.9M | $3.3M | $5.2M | $7.5M |
| Generales y Administrativos | $3.4M | $3.2M | $3.0M | $3.5M | $4.3M | $5.0M | $6.7M | $4.5M | $4.2M | $4.4M |
| Gastos Operativos | $7.7M | $8.0M | $8.4M | $10.2M | $18.7M | $12.4M | $13.9M | $7.0M | $9.3M | $11.8M |
| Beneficio Operativo | -$5.7M | -$7.6M | -$9.1M | -$10.5M | -$18.6M | -$13.1M | -$14.2M | -$7.7M | -$9.4M | -$11.8M |
| EBITDA | -$5.6M | -$7.5M | -$9.0M | -$10.1M | -$18.5M | -$12.5M | -$14.1M | -$7.7M | -$9.5M | -$11.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $10882 | $904502 | $822611 | $49129 | 0 | 0 |
| Beneficio Antes de Impuestos | -$3.8M | -$7.6M | -$8.9M | -$10.0M | -$18.5M | -$13.4M | -$15.0M | -$7.9M | -$8.7M | -$11.6M |
| Impuestos | -$530000 | -$417000 | 0 | -$610676 | -$836893 | -$864742 | -$1.2M | -$1.8M | -$409114 | -$506615 |
| Beneficio Neto | -$3.2M | -$7.1M | -$8.9M | -$9.4M | -$17.7M | -$12.6M | -$13.8M | -$6.1M | -$8.3M | -$11.1M |
| BPA | $-223.20 | $-278.40 | $-162.09 | $-115.88 | $-154.45 | $-67.54 | $-76.96 | $-12.66 | $-4.98 | $-2.14 |
| BPA Diluido | $-321.60 | $-278.40 | $-162.09 | $-115.88 | $-154.45 | $-75.06 | $-76.89 | $-12.66 | $-4.98 | $-2.14 |
| Acciones en Circulación (Diluidas) | $14932 | $25601 | $54909 | $80735 | $114529 | $185797 | $179459 | $484877 | $1.7M | $5.2M |
Precio
| Precio | $0.36 |
| Capitalización | $5M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CANF · CMND · ENSC · KZIA · OGEN · QLGN · SILO
Explorar sector: Healthcare · Biotechnology
Más secciones de SNGX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones